CRISPRとCas遺伝子の世界市場レポート 2025年

CRISPRとCas遺伝子市場規模は、今後数年で飛躍的な成長が見込まれます。2029年の年間平均成長率（CAGR）は22.2％で、108億1,000万米ドルに成長します。予測期間中の成長は、禁止事項の世界的拡大、消費者意識の高まり、新ブランドの出現、消費者教育への取り組み、美容の包括性に起因しています。予測期間の主な動向には、技術の進歩、製品の革新、循環型美容経済、男性用グルーミングセグメント、社会正義、倫理的調達などが含まれます。

パーソナライズドセラピーへの注目度の高まりが予想され、今後のCRISPRとCas遺伝子市場の成長を牽引するとみられます。個別化治療とは、個人の遺伝子プロファイルを活用して、病気の診断、治療、予防に関する意思決定に役立てることです。CRISPRとCas遺伝子、特にCas9は、個人の遺伝物質に対する正確な改変を可能にすることにより、個別化医療において極めて重要な役割を果たしており、遺伝性疾患、がん、様々な病状に対するテーラーメイド治療における画期的な進歩をもたらす可能性があります。例えば、米国を拠点とする専門家会員組織である個別化医療連合（Personalized Medicine Coalition）のデータによると、2022年に食品医薬品局（FDA）の医薬品評価研究センター（CDER）は37の新規分子化合物（NME）を承認しました。このうち約34％にあたる12品目は、個別化医療連合（PMC）によって個別化医薬品に分類されています。このように、個別化治療に対する需要の高まりは、CRISPRとCas遺伝子市場の成長を促進すると予想されます。

CRISPRとCas遺伝子市場の主なプレーヤーは、CRISPRベースの細胞ベースの遺伝子治療などの革新的な製品を積極的に開発し、製品の提供を強化し、競争力を獲得しています。CRISPRに基づく細胞ベースの遺伝子治療は、CRISPR遺伝子編集技術を利用して細胞内の遺伝物質を改変または修正するものであり、遺伝性疾患、疾病、その他の病状を細胞レベルで治療するための標的化された潜在的に変革的なアプローチを提示するものです。例えば、2023年12月、米国のバイオ医薬品会社であるVertex Pharmaceuticals Incorporatedは、CASGEVY（exagamglogene autotemcel[exa-cel]）について米国食品医薬品局（FDA）から承認を取得しました。CASGEVYはCRISPR/Cas9ゲノム編集遺伝子治療薬で、血管閉塞性クリーゼを再発する12歳以上の鎌状赤血球症（SCD）の管理に適応されます。この世界初の治療法は、対象となる鎌状赤血球患者に1回限りの画期的な治療を提供する可能性があります。バーテックス社は、幹細胞移植の特別なトレーニングを必要とする患者にCASGEVYを投与する承認治療センター（ATC）のネットワークを米国中に構築するため、経験豊富な施設と協力しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界CRISPRとCas遺伝子 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のCRISPRとCas遺伝子市場：成長率分析
• 世界のCRISPRとCas遺伝子市場の実績：規模と成長, 2019-2024
• 世界のCRISPRとCas遺伝子市場の予測：規模と成長, 2024-2029, 2034F
• 世界CRISPRとCas遺伝子総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のCRISPRとCas遺伝子市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キットと酵素
• 図書館
• デザインツール
• 抗体
• その他の製品タイプ
• 世界のCRISPRとCas遺伝子市場：サービスタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞株エンジニアリング
• gRNA設計
• 微生物の遺伝子編集
• DNA合成
• 世界のCRISPRとCas遺伝子市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床
• 金融
• 運用および管理
• 世界のCRISPRとCas遺伝子市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオテクノロジーおよび製薬会社
• 学術機関および政府調査機関
• 契約調査機関（CRO）
• 世界のCRISPRとCas遺伝子市場、キットと酵素の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPRキット
• Cas酵素
• Grna合成キット
• 世界のCRISPRとCas遺伝子市場、ライブラリのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子ノックアウト用 CRISPRライブラリ
• 遺伝子活性化のためのCRISPRライブラリ
• シュグルナ図書館
• 世界のCRISPRとCas遺伝子市場、デザインツールの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンラインデザインプラットフォーム
• CRISPRガイド RNA設計用ソフトウェア
• カスタムデザインサービス
• 世界のCRISPRとCas遺伝子市場抗体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• Casタンパク質に対する抗体
• 編集された細胞を検出するための抗体
• 免疫測定用二次抗体
• 世界のCRISPRとCas遺伝子市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 配送システム
• CRISPR関連消耗品
• コントロールプラスミドと試薬

第7章 地域別・国別分析

• 世界のCRISPRとCas遺伝子市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のCRISPRとCas遺伝子市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• CRISPRとCas遺伝子市場：競合情勢
• CRISPRとCas遺伝子市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lonza Group AG
• Bio-Rad Laboratories Inc.
• eGenesis
• Novartis Institutes for BioMedical Research
• Myriad Genetics Inc.
• GenScript
• Takara Bio Inc.
• 23andMe Inc.
• Merck KGaA
• Color Genomics Inc.
• Horizon Discovery Group Plc
• Beam Therapeutics Inc
• Intellia Therapeutics Inc.
• New England BioLabs
• Recursion Pharmaceuticals Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• CRISPRとCas遺伝子市場2029：新たな機会を提供する国
• CRISPRとCas遺伝子市場2029：新たな機会を提供するセグメント
• CRISPRとCas遺伝子市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, along with the Cas (CRISPR-associated) gene, particularly Cas9, represents a powerful gene-editing technology. This system enables precise modifications to DNA sequences, revolutionizing genetic research, biotechnology, and potential medical applications.

The primary product types within the CRISPR and Cas genes market include kits and enzymes, libraries, design tools, antibodies, and others. Kits and enzymes are fundamental components in the realm of CRISPR-based gene therapy, with kits containing the necessary ingredients and instruments for gene editing research, and enzymes, such as Cas9, playing a pivotal role in the gene editing process. Services are categorized into cell line engineering, gRNA design, microbial gene editing, and DNA synthesis, and find applications across clinical, financial, operational, and administrative domains. End users of these products and services include biotechnology and pharmaceutical companies, academic and government research institutes, as well as contract research organizations (CROs).

The CRISPR and Cas gene research report is one of a series of new reports from The Business Research Company that provides CRISPR and Cas gene market statistics, including the CRISPR and Cas gene industry's global market size, regional shares, competitors with a CRISPR and Cas gene market share, detailed CRISPR and Cas gene market segments, market trends and opportunities, and any further data you may need to thrive in the CRISPR and Cas gene industry. This CRISPR and Cas gene market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The crispr and cas gene market size has grown exponentially in recent years. It will grow from $3.99 billion in 2024 to $4.85 billion in 2025 at a compound annual growth rate (CAGR) of 21.7%. The growth in the historic period can be attributed to increased consumer awareness, shift in consumer values, rise in celebrity endorsements, rise of veganism, increased social media influence.

The crispr and cas gene market size is expected to see exponential growth in the next few years. It will grow to $10.81 billion in 2029 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to global expansion of bans, rising conscious consumerism, emergence of new brands, consumer education initiatives, beauty inclusivity. Major trends in the forecast period include technology advancements, product innovations, circular beauty economy, men's grooming segment, social justice and ethical sourcing.

The anticipated increase in focus on personalized therapy is set to drive the growth of the CRISPR and Cas gene markets in the future. Personalized therapy involves utilizing an individual's genetic profile to inform decisions regarding disease diagnosis, treatment, and prevention. CRISPR and the Cas gene, particularly Cas9, play a pivotal role in personalized medicine by enabling precise modifications to an individual's genetic material, offering potential breakthroughs in tailored therapies for genetic disorders, cancer, and various medical conditions. For example, data from the Personalized Medicine Coalition, a US-based professional membership organization, revealed that in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Among these, approximately 34%, or 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Thus, the growing demand for personalized therapy is expected to fuel the growth of the CRISPR and Cas gene markets.

Key players in the CRISPR and Cas gene markets are actively developing innovative products such as CRISPR-based cell-based gene therapy to enhance their product offerings and gain a competitive edge. CRISPR-based cell-based gene therapy involves utilizing CRISPR gene-editing technology to modify or correct genetic material within cells, presenting a targeted and potentially transformative approach to treating genetic disorders, diseases, and other medical conditions at the cellular level. For instance, in December 2023, Vertex Pharmaceuticals Incorporated, a US-based biopharmaceutical company, obtained approval from the U.S. Food and Drug Administration (FDA) for CASGEVY (exagamglogene autotemcel [exa-cel]). CASGEVY is a CRISPR/Cas9 genome-edited gene therapy indicated for managing sickle cell disease (SCD) in individuals aged 12 and above who experience recurrent vaso-occlusive crises. This first-of-its-kind therapy has the potential to offer a one-time transformative treatment for eligible sickle cell patients. Vertex is collaborating with experienced institutions to establish a network of approved treatment centers (ATCs) across the United States to administer CASGEVY to patients, requiring specific training in stem cell transplantation.

In January 2022, Bayer AG, a Germany-based pharmaceutical company, entered into a collaboration with Mammoth Biosciences to harness the natural richness in advancing the next generation of CRISPR products. This partnership aims to utilize Mammoth's CRISPR systems for developing in vivo gene-editing therapies, enhancing Bayer's emerging cell and gene therapy platform. The collaboration aligns with Mammoth Biosciences' goal of unlocking the full potential of innovative CRISPR systems. Mammoth BioSciences is a US-based biotechnology company specializing in developing CRISPR-Cas gene diagnostic tests.

Major companies operating in the Crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group PLC, Beam Therapeutics Inc., Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc., Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.

North America was the largest region in the CRISPR and Cas gene market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the CRISPR and Cas gene market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The CRISPR and Cas gene market consists of revenues earned by entities by offering services such as gene editing, targeted disruption of genes, targeted drug development, livestock breeding, and animal model construction. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR and Cas gene market also includes sales of RNA clean-up kits, phenol-free kits, t7 polymerase mix, and RNAse-free water. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CRISPR And Cas Gene Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crispr and cas gene market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crispr and cas gene ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crispr and cas gene market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Kits And Enzymes; Libraries; Design Tool; Antibodies; Other Products Types
• 2) By Service Type: Cell Line Engineering; gRNA Design; Microbial Gene Editing; DNA Synthesis
• 3) By Application: Clinical; Financial; Operational And Administrative
• 4) By End Use: Biotechnology And Pharmaceutical Companies; Academics And Government Research Institutes; Contract Research Organizations (CROs)
• Subsegments:
• 1) By Kits And Enzymes: CRISPR Kits; Cas Enzymes; Grna Synthesis Kits
• 2) By Libraries: CRISPR Libraries For Gene Knockout; CRISPR Libraries For Gene Activation; Sgrna Libraries
• 3) By Design Tools: Online Design Platforms; Software For CRISPR Guide RNA Design; Custom Design Services
• 4) By Antibodies: Antibodies For Cas Proteins; Antibodies For Detection Of Edited Cells; Secondary Antibodies For Immunoassays
• 5) By Other Product Types: Delivery Systems; CRISPR-Related Consumables; Control Plasmids And Reagents
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc; AstraZeneca plc.; Danaher Corporation; Quest Diagnostics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. CRISPR And Cas Gene Market Characteristics

3. CRISPR And Cas Gene Market Trends And Strategies

4. CRISPR And Cas Gene Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global CRISPR And Cas Gene Growth Analysis And Strategic Analysis Framework

• 5.1. Global CRISPR And Cas Gene PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global CRISPR And Cas Gene Market Growth Rate Analysis
• 5.4. Global CRISPR And Cas Gene Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global CRISPR And Cas Gene Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global CRISPR And Cas Gene Total Addressable Market (TAM)

6. CRISPR And Cas Gene Market Segmentation

• 6.1. Global CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits And Enzymes
• Libraries
• Design Tool
• Antibodies
• Other Products Types
• 6.2. Global CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Line Engineering
• gRNA Design
• Microbial Gene Editing
• DNA Synthesis
• 6.3. Global CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical
• Financial
• Operational And Administrative
• 6.4. Global CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology And Pharmaceutical Companies
• Academics And Government Research Institutes
• Contract Research Organizations (CROs)
• 6.5. Global CRISPR And Cas Gene Market, Sub-Segmentation Of Kits And Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Kits
• Cas Enzymes
• Grna Synthesis Kits
• 6.6. Global CRISPR And Cas Gene Market, Sub-Segmentation Of Libraries, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Libraries For Gene Knockout
• CRISPR Libraries For Gene Activation
• Sgrna Libraries
• 6.7. Global CRISPR And Cas Gene Market, Sub-Segmentation Of Design Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Design Platforms
• Software For CRISPR Guide RNA Design
• Custom Design Services
• 6.8. Global CRISPR And Cas Gene Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibodies For Cas Proteins
• Antibodies For Detection Of Edited Cells
• Secondary Antibodies For Immunoassays
• 6.9. Global CRISPR And Cas Gene Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Delivery Systems
• CRISPR-Related Consumables
• Control Plasmids And Reagents

7. CRISPR And Cas Gene Market Regional And Country Analysis

• 7.1. Global CRISPR And Cas Gene Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global CRISPR And Cas Gene Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific CRISPR And Cas Gene Market

• 8.1. Asia-Pacific CRISPR And Cas Gene Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China CRISPR And Cas Gene Market

• 9.1. China CRISPR And Cas Gene Market Overview
• 9.2. China CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India CRISPR And Cas Gene Market

• 10.1. India CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan CRISPR And Cas Gene Market

• 11.1. Japan CRISPR And Cas Gene Market Overview
• 11.2. Japan CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia CRISPR And Cas Gene Market

• 12.1. Australia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia CRISPR And Cas Gene Market

• 13.1. Indonesia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea CRISPR And Cas Gene Market

• 14.1. South Korea CRISPR And Cas Gene Market Overview
• 14.2. South Korea CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe CRISPR And Cas Gene Market

• 15.1. Western Europe CRISPR And Cas Gene Market Overview
• 15.2. Western Europe CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK CRISPR And Cas Gene Market

• 16.1. UK CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany CRISPR And Cas Gene Market

• 17.1. Germany CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France CRISPR And Cas Gene Market

• 18.1. France CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy CRISPR And Cas Gene Market

• 19.1. Italy CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain CRISPR And Cas Gene Market

• 20.1. Spain CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe CRISPR And Cas Gene Market

• 21.1. Eastern Europe CRISPR And Cas Gene Market Overview
• 21.2. Eastern Europe CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia CRISPR And Cas Gene Market

• 22.1. Russia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America CRISPR And Cas Gene Market

• 23.1. North America CRISPR And Cas Gene Market Overview
• 23.2. North America CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA CRISPR And Cas Gene Market

• 24.1. USA CRISPR And Cas Gene Market Overview
• 24.2. USA CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada CRISPR And Cas Gene Market

• 25.1. Canada CRISPR And Cas Gene Market Overview
• 25.2. Canada CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America CRISPR And Cas Gene Market

• 26.1. South America CRISPR And Cas Gene Market Overview
• 26.2. South America CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil CRISPR And Cas Gene Market

• 27.1. Brazil CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East CRISPR And Cas Gene Market

• 28.1. Middle East CRISPR And Cas Gene Market Overview
• 28.2. Middle East CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa CRISPR And Cas Gene Market

• 29.1. Africa CRISPR And Cas Gene Market Overview
• 29.2. Africa CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. CRISPR And Cas Gene Market Competitive Landscape And Company Profiles

• 30.1. CRISPR And Cas Gene Market Competitive Landscape
• 30.2. CRISPR And Cas Gene Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

31. CRISPR And Cas Gene Market Other Major And Innovative Companies

• 31.1. Lonza Group AG
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. eGenesis
• 31.4. Novartis Institutes for BioMedical Research
• 31.5. Myriad Genetics Inc.
• 31.6. GenScript
• 31.7. Takara Bio Inc.
• 31.8. 23andMe Inc.
• 31.9. Merck KGaA
• 31.10. Color Genomics Inc.
• 31.11. Horizon Discovery Group Plc
• 31.12. Beam Therapeutics Inc
• 31.13. Intellia Therapeutics Inc.
• 31.14. New England BioLabs
• 31.15. Recursion Pharmaceuticals Inc

32. Global CRISPR And Cas Gene Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The CRISPR And Cas Gene Market

34. Recent Developments In The CRISPR And Cas Gene Market

35. CRISPR And Cas Gene Market High Potential Countries, Segments and Strategies

• 35.1 CRISPR And Cas Gene Market In 2029 - Countries Offering Most New Opportunities
• 35.2 CRISPR And Cas Gene Market In 2029 - Segments Offering Most New Opportunities
• 35.3 CRISPR And Cas Gene Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer